Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Cervical cancer and use of hormonal contraceptives: a systematic review.

Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V.

Lancet. 2003 Apr 5;361(9364):1159-67. Review.

PMID:
12686037
2.

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.

Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group.

Lancet. 2002 Mar 30;359(9312):1085-92.

PMID:
11943255
3.

Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.

International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodhill A, Green J, Peto J, Plummer M, Sweetland S.

Lancet. 2007 Nov 10;370(9599):1609-21. Review.

PMID:
17993361
4.

Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa).

Shapiro S, Rosenberg L, Hoffman M, Kelly JP, Cooper DD, Carrara H, Denny LE, du Toit G, Allan BR, Stander IA, Williamson AL.

Cancer Causes Control. 2003 Jun;14(5):485-95.

PMID:
12946044
5.

The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review.

Moodley M, Moodley J, Chetty R, Herrington CS.

Int J Gynecol Cancer. 2003 Mar-Apr;13(2):103-10. Review.

PMID:
12657108
7.

Risk factors for cervical neoplasia in Denmark.

Kjaer SK.

APMIS Suppl. 1998;80:1-41.

PMID:
9693662
8.

The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.

Daling JR, Madeleine MM, McKnight B, Carter JJ, Wipf GC, Ashley R, Schwartz SM, Beckmann AM, Hagensee ME, Mandelson MT, Galloway DA.

Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):541-8.

9.
10.

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group.

J Natl Cancer Inst. 2006 Mar 1;98(5):303-15.

11.

Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study.

Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjosé S, Muñoz N; IARC Multi-centre Cervical Cancer Study Group.

Cancer Causes Control. 2003 Nov;14(9):805-14.

PMID:
14682438
12.

[Possible link between long-term oral contraceptive use and cervical cancer].

[No authors listed]

Perspect Int Planif Fam. 1987;(Spec No):40-1. Spanish.

PMID:
12269054
13.

Oral contraceptives and breast cancer risk among younger women.

Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, Coates RJ, Gammon MD, Hanson L, Hoover RN.

J Natl Cancer Inst. 1995 Jun 7;87(11):827-35.

PMID:
7791232
14.

Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.

Lacey JV Jr, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Silverberg SG, Hildesheim A.

Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1079-85.

15.

Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.

Urban M, Banks E, Egger S, Canfell K, O'Connell D, Beral V, Sitas F.

PLoS Med. 2012;9(3):e1001182. doi: 10.1371/journal.pmed.1001182. Epub 2012 Mar 6.

16.

A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.

Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG, Studentsov YY, McAdams M, Schiffman M.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1574-82.

17.

Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections.

Syrjänen K, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Santopietro R, Cintorino M, Tosi P, Syrjanen S.

Anticancer Res. 2006 Nov-Dec;26(6C):4729-40.

18.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
19.
20.

Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women.

McFarlane-Anderson N, Bazuaye PE, Jackson MD, Smikle M, Fletcher HM.

BMC Womens Health. 2008 May 30;8:9. doi: 10.1186/1472-6874-8-9.

Items per page

Supplemental Content

Write to the Help Desk